The newly launched quadripolar LV lead features a double bend shape which the Abbott Park, Ill.-based company said will aid in patient optimization in combination with its MultiPoint pacing and SyncAV technology, according to a press release.
Abbott touted the quadripolar leads, saying the Quartet lead design allows for implantation in the “most stable position” without sacrificing electrical performance. The company said that data from more than 130 clinical publications support the use of the quadripolar leads.
In March, Abbott said it won FDA approval for its sensor-enabled FlexAbility ablation catheter designed for cardiac ablation procedures to treat atrial flutter.
The sensor-enabled FlexAbility ablation catheter is the company’s 1st designed to collect electrical current resistance and magnetic data to produce accurate mapping and assist in treating sites that trigger or sustain abnormal heart rhythms.
The device is also compatible for use with the EnSite Precision cardiac mapping system, the company said, which allows for the creation of highly detailed 3D cardiac models with the heart’s electrical activity overlaid on it.